UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 10 | October 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 1
January-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2401207


Registration ID:
531253

Page Number

c55-c62

Share This Article


Jetir RMS

Title

A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF VAMANA KARMA WITH IKSWAKU AND MADANAPHALA IN THE MANAGEMENT OF PREDIABETES

Abstract

Prediabetes is one of the major healthcare issues in the present times owing to its impact on the quality of life and risk of diabetes mellitus and other micro and macro-vascular diseases. It is a state of intermediate hyperglycemia which is a reversible state from where an individual can progress to diabetes or revert to normalcy. The reversal is majorly by employing diet modification, lifestyle management and timely detoxification and rejuvenation therapy to repair the impaired metabolism. . Prediabetes according to the Ayurvedic perspective falls under the umbrella of Santarpanottha Vikara and can be understood as the premonitory stage of Prameha i.e. Purvaroopa or a clinically reversible stage with good prognosis i.e. Kaphaja Prameha. Prameha is Kapha Pradhana Tridhoshaja Vyadhi and Shodhana is the main line of treatment in such conditions, particularly Vamana. Considering these, comparative clinical study aimed to assess the effectiveness of Vamana Karma using Madanphala (group A) and Ikshvaku (group B) in prediabetes management. Procedural and disease-specific parameters (FBS, PPBS, HbA1c) were evaluated. Following intervention, both groups exhibited a significant reduction in blood glucose levels. Group A demonstrated superior outcomes, with a mean reduction in FBS by 11.7 mg/dl, PPBS by 19.9, and HbA1c by 0.32, all statistically significant (p < 0.05).In conclusion, both interventions proved effective, but Madanaphala emerged as a preferable choice for Vamana compared to Ikshwaku, considering both Rogagnatha and Karmukata. This study highlights the potential of Ayurvedic approaches, emphasizing tailored treatments for prediabetes to mitigate its impact on individuals' well-being.

Key Words

Prediabetes; Kaphaja Prameha; Vamana; Madanaphala; Ikshwaku

Cite This Article

"A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF VAMANA KARMA WITH IKSWAKU AND MADANAPHALA IN THE MANAGEMENT OF PREDIABETES", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 1, page no.c55-c62, January-2024, Available :http://www.jetir.org/papers/JETIR2401207.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF VAMANA KARMA WITH IKSWAKU AND MADANAPHALA IN THE MANAGEMENT OF PREDIABETES", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 1, page no. ppc55-c62, January-2024, Available at : http://www.jetir.org/papers/JETIR2401207.pdf

Publication Details

Published Paper ID: JETIR2401207
Registration ID: 531253
Published In: Volume 11 | Issue 1 | Year January-2024
DOI (Digital Object Identifier):
Page No: c55-c62
Country: Mysore, Karnataka, India .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000333

Print This Page

Current Call For Paper

Jetir RMS